Institutional Ownership Ptc Therapeutics, Inc. (PTCT)
This table provides information about the institutional ownership of Ptc Therapeutics, Inc. (PTCT). We have compiled data on the 220 institutions that hold shares in the stock, with a total of 78.1 Million shares, which have been reported (via 13F filing form) to have a value of $3.52 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Steward Financial Group LLC
|
Oct 20, 2023 Q3 2023 |
15
shares
|
$659
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
12
shares
|
$527
0.0% of portfolio
|
Q2 2022
Reduced 90.63%
|
|
|
Sjs Investment Consulting Inc.
Sylvania, OH |
Oct 16, 2024 Q3 2024 |
11
shares
|
$483
0.0% of portfolio
|
Q2 2024
Added 57.14%
|
|
|
Riggs Asset Managment Co. Inc.
|
Oct 24, 2024 Q3 2024 |
11
shares
|
$483
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Di Nuzzo Private Wealth, Inc.
Beaver, PA |
Oct 16, 2024 Q3 2024 |
9
shares
|
$395
0.0% of portfolio
|
Q3 2024
Added 50.0%
|
|
|
Ronald Blue Trust, Inc.
Brentwood, TN |
Oct 17, 2024 Q3 2024 |
9
shares
|
$395
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Covestor LTD
Boston, MA |
Nov 01, 2024 Q3 2024 |
5
shares
|
$219
0.0% of portfolio
|
Q1 2024
Reduced 16.67%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|